Aflofarm with PLN 26 mln fine from UOKiK

Antitrust watchdog UOKiK has slapped a PLN 26 million fine on pharma producer Aflofarm Farmacja Polska. The fine is for the misleading commercial of Aflofarm’s sinus infection Renopuren dietary supplement which “were advertised in a manner suggestive of actual medical properties.” According to Polish law dietary supplements cannot be advertised as medicine or in a…

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It